Hepatology Highlights

Alcohol-Associated Liver Disease On the Rise: What to Know Dr Nancy Reau speaks with hepatologist Dr Ashwani Singal about how to identify alcohol-associated liver disease, the most common cause of advanced hepatic disease worldwide.
Experts And Viewpoints, March 11, 2024
The Breakthrough Drug Whose Full Promise Remains Unrealized With its approval in 2013, sofosbuvir revolutionized treatment for hepatitis C, but the goal of eliminating this disease is still decades away.
Experts And Viewpoints, January 22, 2024
New ACG Guidelines Offer Key Advice on Acute Liver Failure Dr Nancy Reau speaks with Dr Alexandra Shingina, lead author behind the guidelines, about the special considerations required for managing this rare condition.
Experts And Viewpoints, September 25, 2023
MASLD: Promising Treatments for a Newly Renamed Disease The fresh perspective on the formerly named NAFLD is reflected in several novel drugs that place the focus on metabolic syndrome.
Experts And Viewpoints, September 14, 2023
Why Are NAFLD Treatments Failing in Clinical Trials? Dr Vlad Ratziu, professor of hepatology at the Sorbonne Université, shares his thoughts on why treatments for fatty liver disease continue to fall short, in a conversation with Dr Nancy Reau.
Experts And Viewpoints, April 17, 2023
Much-Needed Guidance Arrives on Drug-Induced Liver Injury Dr Nancy Reau speaks with Dr Robert Fontana, the co-author of recent guidance from the AASLD on how to diagnose and manage the harmful consequences of certain drugs and unregulated supplements.
Experts And Viewpoints, November 21, 2022
Don't Overlook NAFLD in Lean Patients Dr Nancy Reau speaks with gastroenterologist Dr Michelle Long about the challenges of identifying and treating NAFLD in patients without obesity.
Experts And Viewpoints, August 30, 2022
What to Know About New Guidelines on Systemic HCC Therapy Dr Nancy Reau speaks with HCC expert Dr Amit Singal on how these 11 new recommendations may change how you approach this increasingly common cancer.
Experts And Viewpoints, April 29, 2022
ACG Offers Guidelines for Acute-on-Chronic Liver Failure A conversation with the lead author behind the recently published recommendations on how to manage this major cause of mortality in patients with chronic liver disease.
Experts And Viewpoints, March 07, 2022
Treating NAFLD by Defeating Obesity: What Are the Best Options? Bariatric surgery is often the treatment of last resort, but considering it earlier may be just what patients with fatty liver disease need.
Experts And Viewpoints, January 21, 2022
HCV Screening in Pregnancy: Casualties in the Quest for Elimination A hepatologist and an obstetrician debate the value of new recommendations to expand HCV screening to all pregnant women.
Experts And Viewpoints, November 22, 2021
GI Cancer and Obesity: Fighting One Means Addressing the Other Patient awareness of obesity's link to gastrointestinal cancer is limited. This overview will help you make the case on why weight management may help them avoid serious disease.
Experts And Viewpoints, October 06, 2021
The Alcohol Pandemic: Are We Ready for What's Next? Drinking and obesity are on the rise, creating a perfect storm for liver disorders in our patients.
Experts And Viewpoints, May 25, 2021
Liver Cancer Rates Are Rising; So Is Optimism Around Its Treatment Dr Nancy Reau shares the promising data leading her to believe that the trends around liver cancer can soon be reversed.
Experts And Viewpoints, November 20, 2020
Vanquishing Hepatitis C: A Remarkable Success Story A look back at one of the singular achievements in medical research of the past 25 years, and what improvements are still to come.
Experts And Viewpoints, November 17, 2020
Obeticholic Acid for NASH: Revolution or Just a Ripple? With FDA approval likely by year's end, Drs Jason Kramer and Nancy Reau consider what obeticholic acid may mean for this increasingly prevalent disease.
Experts And Viewpoints, July 10, 2020
COVID-19's Impact -- Don't Overlook the Liver Dr Nancy Reau looks at the hepatotoxic and gastrointestinal implications of this viral pandemic.
Experts And Viewpoints, March 20, 2020
Hepatocellular Carcinoma: 5 Things to Know Get up to speed on the latest data surrounding the most common form of liver cancer.
Experts And Viewpoints, February 14, 2020
5 Liver-Saving Strategies for the New Year Although the holidays can wreak havoc on the liver, patients can use simple interventions to modify their risk for the most common life-threatening liver diseases. Here's how.
December 23, 2019
Hepatitis C: 5 Things to Know Despite HCV being a curable disease with short-duration, well-tolerated finite therapy, it cannot be dismissed yet. Here are five issues that still need attention.
July 05, 2019

No Results